bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2960
-0.0639 (-17.75%)
At close: Jun 27, 2025, 4:00 PM
0.2851
-0.0109 (-3.68%)
After-hours: Jun 27, 2025, 7:59 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $8.15 million as of June 27, 2025. Its market cap has decreased by -69.07% in one year.
Market Cap
8.15M
Enterprise Value
10.13M
1-Year Change
-69.07%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $8.15M, a decrease of -81.90%. That is a compound annual growth rate of -45.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 9.91M | -30.14% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |